Manipulation of the Th1/Th2 balance in autoimmune disease

Current Opinion in Immunology

Volumn 8, Issue 6, 1996, Pages 837-842

  Nicholson, Lindsay B ^a   Kuchroo, Vijay K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN;

AUTOIMMUNITY; HELPER CELL; SHORT SURVEY;

EID: 0030472449     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80013-6     Document Type: Article

References (62)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clones. J Immunol 1986, 136:2348-2357.
2. + T cells: specificity and function. Immunol Rev 1988, 101:39-80.
3. Sher A, Coffman RL: Regulation of immunity to parasites and T cell-derived cytokines. Annu Rev Immunol 1992, 10:385-409.
4. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 1994, 76:241-251.
5. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994, 12:227-257.
6. Bucy RP, Panoskaltsis-Mortari A, Huang G, Li J, Karr L, Ross M, Russell JH, Murphy KM, Weaver CT: Heterogeneity of single cell cytokine gene expression in clonal T cell populations. J Exp Med 1994, 180:1251-1262,
7. + T-cell phenotype development Proc Natl Acad Sci USA 1995, 92:7565-7559.
8. Openshaw P, Murphy EE, Hosken NA. Maino V, Davis K, Murphy K, O'Garra A: Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations, J Exp Med 1995, 182:1357-1367.
9. Kelso A: Th1 and Th2 subsets: paradigms lost? Immunol Today 1996, 16:374-379.
10. Murphy E, Shibuya K, Hosken N, Openshaw P, Maino V, Davis K, Murphy KM, O'Garra A: Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med 1996, 183:901-913.
11. Zamvil SS, Steinman L: The T lymphocyte in experimental allergic encephalomyelitis. Anna Rev Immunol 1990, 8:579-621.
12. Kuchroo VK, Martin CA, Greer JM, Ju ST, Sobel RA, Dorf ME: Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 1993, 151:4371-4382.
13. + T cells specific for a pancreatic antigen differentiated into Th1 or Th2 phenotypes in vitro. Adoptive transfer of Th1 cells precipitated diabetes whereas Th2 cells infiltrated pancreatic islets but did not initiate diabetes. In experiments mixing transgenic T cells, Th2 cells did not inhibit diabetes induced with transgenic Th1 cells
14. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA: CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset diabetes in NOD mice in the absence of CD4 cells. J Exp Med 1996, 183:67-75.
15. Kuchroo VK, Prabhu Das M, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulalory molecules activate differentially the Th1 /Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995, 80:707-718. Mice treated with anti-B7-1 antibodies at the time of induction of EAE are protected from disease. This protection is due to immure deviation as shown by the cytokine phenotype of the immune response to the encephalitogenic peptide and by the cloning and transfer of protective, antigen-specific Th2 cells. Administration of anti-B7-2 antibodies exacerbated EAE and this was associated with an increase in levels of Th1 cytokines.
16. Chen Y, Ktchroo VK, Inobe J, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237-1240.
17. Khoruts A, Miller SD, Jenkins MK: Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J Immunol 1995, 155:5011-5017. In this paper, the investigators developed techniques to generate polarized Th1 and Th2 populations in vitro. They generated the following populations: highly polarized Th1 cells which cause severe EAE on transfer into naive hosts and highly polarized Th2 cells which neither transfer disease nor confer protection on cotransfer with Th1 cells. They also found, however, that cells with a mixed phenotype, which caused mild disease on transfer into naive mice, diminished the severity of disease when cotransfered with Th1 cells.
18. Ferber IA, Brocke S, Taylor-Edwards G, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG: Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996, 156:5-7. Mice with a disrupted IFN-γ gene were crossed with EAE-susaeptible B10.PL mice. B10.PL mice with IFN-γ deficiency were susceptible to EAE with no difference in severity or incidence.
19. -/- mice.
20. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Rocken M: Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease, J Exp Med 1994, 180:1961-1956.
21. Rocken M, Racke MK, Shevach EM: IL-4 induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 1996, 17:225-231.
22. Moritani M, Yoshimoto K, Tashiro F, Hashimoto C, Miyazaki J, Li S, Kudo E, Iwahana H, Hayashi Y, Sano T, Itakura M: Transgenic expression of IL-10 in pancreatic islet a cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int Immunol 1994, 6:1829-1837.
23. Wogensen L, Lee M, Sarvetnick N: Production of interleukin-10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J Exp Med 1994. 179:1379-1384.
24. 7 allele, but no other known diabetes susceptibility alleles, shows that the local expression of IL-10 in the context of a susceptible MHC is sufficient for the development of diabetes.
25. Miller A, Lider O, Weiner HL: Antigen-driven bystander suppression after oral administration of antigen. J Exp Med 1991, 174:791-798.
26. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc Natl Acsd Sci USA 1992, 89:421-425.
27. -/- mice it was shown that the regulation of colitis was independent of IL-4 production in the regulatory cell population. In contrast, TGF-β was critical to the prevention of disease since administration of anti-TGF-β in vivo abrogated protection.
28. Neurath ME, Fuss I, Kelsall BL, Presky DH, Waegell W, Sirober W: Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Erp Mad 1996, 183:2605-2616.
29. + cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 1996, 45:71-78.
30. Khoury SJ, Akalin E, Chardraker A, Turka LA, Linsley PS. Sayegh MH, Hancock WW: CD23-B7 costimulatory blockade by CTLA4lg prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol 1995, 155:4521-4524.
31. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA: Differential effects of anti-B7-1 and anti-B7-2 MAb treatment on the development of diabetes in the NOD mouse. J Exp Med 1995, 181:1145-1155. Early (but not late) treatment of NOD mice with CTLA-4-lg or anti-B7-2 antibodies reduced the incidence of diabetes in NOD mice without abolishing insulitis. In contrast, early anti-B7-1 treatment accelerates the onset of diabetes.
32. Del Prete G, De Carli M, D'Elios MM, Daniel KC, Almerigogna F, Alderson M, Smith CA, Thomas E, Romagnani S: CD30-mediated signaling promotes the development of human T helper type 2-like T cells, J Exp Med 1995, 182:1655-1661.
33. Biancone L, Andres G, Ahn H, Lim A, Dai C, Noelle R, Yagita H, De Martino C, Stamenkovic I: Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type 2-mediated auto immune disease. J Exp Med 1996, 183:1473-1431.
34. + T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J Exp Med 1995, 182:5-13,
35. Saoudi A, Simmonds S, Huitinga I, Mason D: Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J Exp Med 1995, 182:335-344. Lewis rats treated with encephalitogenic MBP covalently linked to anti-lgD were protected from EAE. This paper shows that such treatment induces a Th2-type cytokine response and that protection is partially reversed by the administration of a neutralizing anti-IL-4 antibody. Furthermore, treatment produced a striking reduction in the level of leukocyte infiltration within the brain.
36. Stockinger B, Zal T, Zal A, Gray D: B cells solicit their own help from T cells. J Exp Med 1996, 183:891-899.
37. Chen Y, Inobe J. Marks R, Gonnella P, Kuchroo VK, Weiner HL: Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995, 376:177-180,
38. Weiner HL: Oral tolerance: immune mechanisms and treatment of autoimmune diseases, Immunol Today 1996, in press.
39. Tian J, Atkinson MA, Clare-Salzer M, Hershenfeld A, Forsthuber T, Lehmann PV, Kaufman DL: Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996, 183:1561-1567. Nasal administration of glutamate decarboxylase 65 peptides protected NOD mice form trie development of diabetes. Protection was associated with the production of anti-glutamate decarboxylase antibody isotypes consistent with a Th2 response, with a reduction in peptide-specific IFN-γ and an increase in peptide-specific IL-5. The data suggests that this treatment induced a regulatory Th2 response which inhibited the development of disease.
40. Forsthuber T, Yip HC, Lehmann PV: Induction of Th1 and Th2 immunity in neonatal mice. Science 1996, 271:1728-1730. Tolerizing adult mice and neonatal mice with antigen and incomplete Freund's adjuvant leads to the development of a Th2 response with reciprocal changes in IFN-γ and IL-5 detected by enzyme-linked immunospot assay.
41. Singh RR, Hahn BH, Sercarz EE: Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity. J Exp Med 1996, 183:1613-1621. Neonatal immunization leads to immune deviation which in lupjs-prone New Zealand black/New Zealand white F1 mice results in increases in the levels of antibodies to double-stranded DNA.
42. Wraith DC, Smilek DE, Mitchell DJ, Stainman L, McDevitt HO: Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 1989, 59:247-255.
43. Wraith DC, McDevitt HO, Steinman L, Acha-Orbea H: T cell recognition as the target for immune intervention in autoimmune disease. Cell 1989, 57:709-715.
44. Smilek DE, Wraith DC, Hodgkinson S, Dwivedy S, Steinman L, McDevitt HO: A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 1991, 88:9633-9637.
45. Wauben MHM, Boog CJP, Van der Zee R, Joosten l, Schlief A, Van Eden W: Disease inhibition by major histocompatability complex binding peptide analogues of disease-associated epitopes: more than blocking alone. J Exp Med 1992, 176:667-677.
46. De Magistris MT, Alexander J, Coggeshall M, Altman A, Gaete FCA, Grey HM, Sette A: Antigen analog-major histocompatability complexes act as antagonists of the T cell receptor. Cell 1992, 68:625-634.
47. Sloan-Lancaster J, Evavold BD, Allen PM: Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 1993, 363:156-159.
48. Evavold BD, Allen PM: Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 1991, 252:1308-1310,
49. Kumar V, Bhardwaj V, Scares L, Alexander J, Sette A, Sercarz E: Major histocompatability complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or Interferon gamma by T cells. Proc Natl Acad Sci USA 1995, 92:9510-9514.
50. Chaturvedi P, Yu Q, Southwood S, Sette A, Singh B: Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells, int Immunol 1996, 8:745-755
51. + T cells. J Exp Med 1995, 182:1591-1596.
52. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J Exp Med 1895, 182:1579-1584.
53. Takacs K, Douek DC, Altmann DM: Exacerbated autoimmunity associated with a T helper-1 cytokine profile shift in H-2E-transgenic mice. Eur J Immunol 1995, 25:3134-3141.
54. b allele on the response to allo-4-hydoxyphenylpyruvate dioxygenase. Eur J Immunol 1995, 25:3285-3289.
55. Nicholson LB, Greer JM, Sobel RA, Lees MA, Kuchroo VK; An altered peptide ligand mediates immune deviation and prevents experimental autoimmune encephalomyelitis. Immunity 1995, 3:397-405. An APL which protects mice from the development of EAE induces the generation of T cells that ara cross-reactive with the native peptide. The phenotype of the immune response to the altered peptide is Th0/Th2 and therefore immune deviation has occurred despite immunization in complete Freund's adjuvant. T cells from mice immunized with the altered peptide can transfer protection to naive mice, and protection is partially reversed by treatment with anti-IL-4 monoclonal antibodies.
56. Brocke S, Gijbels K, Allegretta M, Ferber I, Piercy C, Blankenstein T, Martin R, Utz U, Karin N, Mitchell DJ et al.: Treatment of experimental encephalomyetitis with a peptide analogue of myelin basic protein. Nature 1996, 379:343-346. EAE induced by transfer of encephalitcgenic T cell lines or clones in the presence of a T cell clone specific for MBP87-99 was reversed by the administration of soluble native peptide or an analogue of it. The reversal of disease was prevented by neutralizing IL-4 and was associated with regression of inflammatory infiltrates within the brain.
57. Burstein HJ, Abbas AK: In viva role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J Exp Med 1993, 177:457-463.
58. Khoury SJ, Hancock WW, Weiner HL: Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor-β, inlerleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992, 176:1355-1364.
59. Thierielder WE, Van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DAA, Doherty PC, Grosveld GC, Ihle JN: Requirement for Stat4 in interleukin-12-mediated response of natural killer and T cells. Nature 1996, 382:171-174
60. Kaplan MH, Sun, Y, Hoey T, Grusby MJ: Impaired 11-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996, 382:174-177.
61. Takada K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S: Essential role of State in IL-4 signalling. Nature 1996, 380:627-630.
62. Shimoda K, Vandeursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DAA et al.: Lack of IL-4 induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996, 380:630-633.